Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2009

01-10-2009 | Original Article

Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure

Authors: Hisako Ushio, Tomoaki Ishigami, Naomi Araki, Shintaro Minegishi, Koichi Tamura, Yasuko Okano, Kazuaki Uchino, Osamu Tochikubo, Satoshi Umemura

Published in: Clinical and Experimental Nephrology | Issue 5/2009

Login to get access

Abstract

Background

Recent evidence indicates that both ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM) are more useful than the measurement of office blood pressure for evaluating cardiovascular risks in subjects with hypertension. The major advantage of ABPM over HBPM is the ability to measure nighttime blood pressure and ambulatory blood pressure during the day. A newly developed, programmable HBPM device (HEM-5041, OMRON, Kyoto, Japan) can record blood pressure up to 350 times and measure nighttime blood pressure automatically.

Methods

To validate the utility, feasibility, and safety of this device, we measured blood pressure by HBPM using HEM-5041 and by ABPM and compared the values in healthy volunteers.

Results

As compared with ABPM, daytime blood pressures, coefficients of variation for systolic blood pressure, diastolic blood pressure, and pulse rate, and the percentage nighttime fall in these variables were significantly lower with HBPM. However, nighttime blood pressures did not significantly differ between HBPM and ABPM. The results of a questionnaire survey indicated that the subjects were more comfortable when blood pressure was measured by HBPM than by ABPM, whereas the quality of sleep was similar.

Conclusions

Our results suggest that HEM-5041 is useful for evaluating nighttime blood pressures as well as nighttime blood pressure falls, without causing clinically significant discomfort.
Literature
1.
go back to reference Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028–34.CrossRef Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028–34.CrossRef
2.
go back to reference Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213:1143–52.CrossRef Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213:1143–52.CrossRef
3.
go back to reference Anan F, Masaki T, Fukunaga N, Teshima Y, Iwao T, Kaneda K, et al. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus. Eur J Clin Invest. 2007;37:709–14.CrossRefPubMed Anan F, Masaki T, Fukunaga N, Teshima Y, Iwao T, Kaneda K, et al. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus. Eur J Clin Invest. 2007;37:709–14.CrossRefPubMed
4.
go back to reference Ohkubo T, Metoki H, Imai Y. Prognostic significance of morning surge in blood pressure: which definition, which outcome? Blood Press Monit. 2008;13:161–2.CrossRefPubMed Ohkubo T, Metoki H, Imai Y. Prognostic significance of morning surge in blood pressure: which definition, which outcome? Blood Press Monit. 2008;13:161–2.CrossRefPubMed
5.
go back to reference Fukunaga H, Ohkubo T, Kobayashi M, Tamaki Y, Kikuya M, Obara T, et al. Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension. J Hypertens. 2008;26:685–90.CrossRefPubMed Fukunaga H, Ohkubo T, Kobayashi M, Tamaki Y, Kikuya M, Obara T, et al. Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension. J Hypertens. 2008;26:685–90.CrossRefPubMed
6.
go back to reference Shintani Y, Kikuya M, Hara A, Ohkubo T, Metoki H, Asayama K, et al. Ambulatory blood pressure, blood pressure variability and the prevalence of carotid artery alteration: the Ohasama study. J Hypertens. 2007;25:1704–10.CrossRefPubMed Shintani Y, Kikuya M, Hara A, Ohkubo T, Metoki H, Asayama K, et al. Ambulatory blood pressure, blood pressure variability and the prevalence of carotid artery alteration: the Ohasama study. J Hypertens. 2007;25:1704–10.CrossRefPubMed
7.
go back to reference Ohkubo T. Prognostic significance of variability in ambulatory and home blood pressure from the Ohasama study. J Epidemiol. 2007;17:109–13.CrossRefPubMed Ohkubo T. Prognostic significance of variability in ambulatory and home blood pressure from the Ohasama study. J Epidemiol. 2007;17:109–13.CrossRefPubMed
8.
go back to reference Kikuya M, Hansen TW, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115:2145–52.CrossRefPubMed Kikuya M, Hansen TW, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115:2145–52.CrossRefPubMed
9.
go back to reference Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.CrossRefPubMed Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.CrossRefPubMed
10.
go back to reference Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971–5.CrossRefPubMed Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971–5.CrossRefPubMed
11.
go back to reference Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004;22:1099–104.CrossRefPubMed Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004;22:1099–104.CrossRefPubMed
12.
go back to reference Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–9.CrossRefPubMed Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342–9.CrossRefPubMed
13.
go back to reference Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–83.CrossRefPubMed Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–83.CrossRefPubMed
14.
go back to reference Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA. 1999;282:539–46.CrossRefPubMed Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA. 1999;282:539–46.CrossRefPubMed
15.
go back to reference El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT. Blood Press Monit. 2003;8:127–33.CrossRefPubMed El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT. Blood Press Monit. 2003;8:127–33.CrossRefPubMed
16.
go back to reference Coleman A, Freeman P, Steel S, Shennan A. Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit. 2006;11:27–32.CrossRefPubMed Coleman A, Freeman P, Steel S, Shennan A. Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit. 2006;11:27–32.CrossRefPubMed
17.
go back to reference Stergiou GS, Yiannes NG, Rarra VC. Validation of the Omron 705 IT oscillometric device for home blood pressure measurement in children and adolescents: the Arsakion School Study. Blood Press Monit. 2006;11:229–34.CrossRefPubMed Stergiou GS, Yiannes NG, Rarra VC. Validation of the Omron 705 IT oscillometric device for home blood pressure measurement in children and adolescents: the Arsakion School Study. Blood Press Monit. 2006;11:229–34.CrossRefPubMed
18.
go back to reference Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG. Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT). Blood Press Monit. 2006;11:165–71.CrossRefPubMed Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG. Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT). Blood Press Monit. 2006;11:165–71.CrossRefPubMed
19.
go back to reference Altunkan S, Iliman N, Altunkan E. Validation of the Omron M6 (HEM-7001-E) upper arm blood pressure measuring device according to the International Protocol in elderly patients. Blood Press Monit. 2008;13:117–22.CrossRefPubMed Altunkan S, Iliman N, Altunkan E. Validation of the Omron M6 (HEM-7001-E) upper arm blood pressure measuring device according to the International Protocol in elderly patients. Blood Press Monit. 2008;13:117–22.CrossRefPubMed
20.
go back to reference Palatini P, Frigo G, Bertolo O, Roman E, Da Corta R, Winnicki M. Validation of the A&D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects’ characteristics. Blood Press Monit. 1998;3:255–60.PubMed Palatini P, Frigo G, Bertolo O, Roman E, Da Corta R, Winnicki M. Validation of the A&D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects’ characteristics. Blood Press Monit. 1998;3:255–60.PubMed
21.
go back to reference Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens. 2004;22:273–80.CrossRefPubMed Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens. 2004;22:273–80.CrossRefPubMed
22.
go back to reference Imai Y. Clinical significance and cost-effectiveness of 24-hour ambulatory blood pressure monitoring. Tohoku J Exp Med. 1995;176:1–15.CrossRefPubMed Imai Y. Clinical significance and cost-effectiveness of 24-hour ambulatory blood pressure monitoring. Tohoku J Exp Med. 1995;176:1–15.CrossRefPubMed
23.
go back to reference Sakuma M, Imai Y, Nagai K, Watanabe N, Sakuma H, Minami N, et al. Reproducibility of home blood pressure measurements over a 1-year period. Am J Hypertens. 1997;10:798–803.CrossRefPubMed Sakuma M, Imai Y, Nagai K, Watanabe N, Sakuma H, Minami N, et al. Reproducibility of home blood pressure measurements over a 1-year period. Am J Hypertens. 1997;10:798–803.CrossRefPubMed
24.
go back to reference Ozawa M, Tamura K, Iwatsubo K, Matsushita K, Sakai M, Tsurumi-Ikeya Y, et al. Ambulatory blood pressure variability is increased in diabetic hypertensives. Clin Exp Hypertens. 2008;30:213–24.CrossRefPubMed Ozawa M, Tamura K, Iwatsubo K, Matsushita K, Sakai M, Tsurumi-Ikeya Y, et al. Ambulatory blood pressure variability is increased in diabetic hypertensives. Clin Exp Hypertens. 2008;30:213–24.CrossRefPubMed
25.
go back to reference Tamura K, Tsurumi Y, Sakai M, Tanaka Y, Okano Y, Yamauchi J, et al. A possible relationship of nocturnal blood pressure variability with coronary artery disease in diabetic nephropathy. Clin Exp Hypertens. 2007;29:31–42.CrossRefPubMed Tamura K, Tsurumi Y, Sakai M, Tanaka Y, Okano Y, Yamauchi J, et al. A possible relationship of nocturnal blood pressure variability with coronary artery disease in diabetic nephropathy. Clin Exp Hypertens. 2007;29:31–42.CrossRefPubMed
26.
go back to reference Chamontin B, Amar J, Garelli-Flores II, Salvador M. Dippers and non-dippers among overweight hypertensive men. Blood Press Monit. 1996;1:329–32.PubMed Chamontin B, Amar J, Garelli-Flores II, Salvador M. Dippers and non-dippers among overweight hypertensive men. Blood Press Monit. 1996;1:329–32.PubMed
27.
go back to reference Butkevich A, Phillips RA, Sheinart KF, Tuhrim S. The effects of various definitions of dipping and daytime and night-time on the characterization of 24 h profiles of blood pressure. Blood Press Monit. 2000;5:19–22.CrossRefPubMed Butkevich A, Phillips RA, Sheinart KF, Tuhrim S. The effects of various definitions of dipping and daytime and night-time on the characterization of 24 h profiles of blood pressure. Blood Press Monit. 2000;5:19–22.CrossRefPubMed
28.
go back to reference Manning G, Rushton L, Donnelly R, Millar-Craig MW. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am J Hypertens. 2000;13:1035–8.CrossRefPubMed Manning G, Rushton L, Donnelly R, Millar-Craig MW. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am J Hypertens. 2000;13:1035–8.CrossRefPubMed
29.
go back to reference Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med. 2000;17:360–4.CrossRefPubMed Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med. 2000;17:360–4.CrossRefPubMed
30.
go back to reference Hermida RC, Ayala DE, Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 2007;59:904–22.CrossRefPubMed Hermida RC, Ayala DE, Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 2007;59:904–22.CrossRefPubMed
31.
go back to reference Mansoor GA. Sleep actigraphy in hypertensive patients with the ‘non-dipper’ blood pressure profile. J Hum Hypertens. 2002;16:237–42.CrossRefPubMed Mansoor GA. Sleep actigraphy in hypertensive patients with the ‘non-dipper’ blood pressure profile. J Hum Hypertens. 2002;16:237–42.CrossRefPubMed
32.
go back to reference Coca A. Circadian rhythm and blood pressure control: physiological and pathophysiological factors. J Hypertens Suppl. 1994;12:S13–21.CrossRefPubMed Coca A. Circadian rhythm and blood pressure control: physiological and pathophysiological factors. J Hypertens Suppl. 1994;12:S13–21.CrossRefPubMed
33.
go back to reference Uzu T, Nishimura M, Fujii T, Takeji M, Kuroda S, Nakamura S, et al. Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy. J Hypertens. 1998;16:1745–8.CrossRefPubMed Uzu T, Nishimura M, Fujii T, Takeji M, Kuroda S, Nakamura S, et al. Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy. J Hypertens. 1998;16:1745–8.CrossRefPubMed
34.
go back to reference Okuguchi T, Osanai T, Kamada T, Kimura M, Takahashi K, Okumura K. Significance of sympathetic nervous system in sodium-induced nocturnal hypertension. J Hypertens. 1999;17:947–57.CrossRefPubMed Okuguchi T, Osanai T, Kamada T, Kimura M, Takahashi K, Okumura K. Significance of sympathetic nervous system in sodium-induced nocturnal hypertension. J Hypertens. 1999;17:947–57.CrossRefPubMed
35.
go back to reference Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:1–9.CrossRefPubMed Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:1–9.CrossRefPubMed
36.
go back to reference Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:10–29.CrossRefPubMedPubMedCentral Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:10–29.CrossRefPubMedPubMedCentral
Metadata
Title
Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure
Authors
Hisako Ushio
Tomoaki Ishigami
Naomi Araki
Shintaro Minegishi
Koichi Tamura
Yasuko Okano
Kazuaki Uchino
Osamu Tochikubo
Satoshi Umemura
Publication date
01-10-2009
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 5/2009
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0192-4

Other articles of this Issue 5/2009

Clinical and Experimental Nephrology 5/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.